HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 26, Issue 4, 2008, Pages 627-631

  Charpin, Caroline ^a   Balandraud, Nathalie ^a   Guis, Sandrine ^a   Roudier, Chantal ^a   Toussirot, Eric ^b   Rak, Justyna ^a   Lambert, Nathalie ^a   Martin, Marielle ^a   Reviron, Denis ^c   Roudier, Jean ^a   Auger, Isabelle ^a  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Anti CCP; HLA DRB1 *0404; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HLA DRB1*0404 ANTIGEN; HLA-DRB1*0404 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; BLOOD; CASE CONTROL STUDY; GENETICS; HOMOZYGOTE; IMMUNOLOGY; MIDDLE AGED; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; SCLERODERMA, SYSTEMIC;

EID: 52749095695     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. OLLIER W, THOMSON W: Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992; 18: 741-59.
2. DEIGHTON CM, WALKER DJ, GRIFFITHS ID, ROBERTS DF: The contribution of HLA to rheumatoid arthritis. Clin Genet 1989; 36: 178-82.
3. GREGERSEN PK, SILVER J, WINCHESTER RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
4. REVIRON D, PERDRIGER A, TOUSSIROT E et al.: Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 2001; 44: 535-40.
5. WORDSWORTH P, PILE KD, BUCKELY JD et al.: HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992; 51: 585-91.
6. SCHELLEKENS GA, DE JONG BA, VAN DEN HOOGEN FH, VAN DE PUTTE LB, VAN VENVOOIJ WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
7. VAN VENROOIJ WJ, PRUIJN GJ: Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000; 2: 249-51.
8. GIRBAL-NEUHAUSER E, DURIEUX JJ, ARNAUD M et al.: The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999; 162: 585-94.
9. SCHELLEKENS GA, VISSER H, DE JONG BA et al.: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
10. VANDER HELM-VAN MIL AH, VERPOORT KN, BREEDVELD FC, HUIZINGA TW, TOES RE, DE VRIES RR: The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117-21.
11. IRIGOYEN P, LEE AT, WENER MH et al.: Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52: 3813-8.
12. VAN GAALEN FA, VAN AKEN J, HUIZINGA TW et al.: Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113-21.
13. HUIZINGA TW, AMOS CI, VAN DER HELM-VAN MIL AH et al.: Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52: 3433-8.
14. FURUYA T, HAKODA M, ICHIKAWA N, HIGAMI K, NANKE Y, YAGO T et al.: Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol. 2007; 25: 219-24.
15. SENKPIEHL I, MARGET M, WEDLER M et al.: HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis. Int Arch Allergy Immunol 2005; 137: 315-8.
16. VAN DER HELM-VAN MIL AH, VERPOORT KN, LE CESSIE S, HUIZINGA TW, DE VRIES RR, TOES RE: The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 2007; 2: 425-32.
17. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
18. OLLERUP O, ZETTERQUIST H: HLA-DR typing PCR amplification with sequence specific primers (PCR-SSP) in two hours; an alternative to DR serological typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
19. THOMSON W, HARRISON B, OLLIER B et al.: Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999; 42: 757-62.
20. ROUDIER J: HLA-DRB1 genes and extraarticular rheumatoid arthritis. Arthritis Res Ther 2006; 8: 103.
21. WEYAND CM, XIE C, GORONZY JJ: Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89: 2033-9.
22. AUGER I, SEBBAG M, VINCENT C et al.: Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum 2005; 52: 3424-31
23. LIGEIRO D, FONSECA JE, ABADE O et al.: Influence of Human Leukocyte Antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population. Ann Rheum Dis 2007; 66: 246-8.
24. AUGER I, ROUDIER C, GUIS S, BALANDRAUD N, ROUDIER J: HLA-DRB1*0404 is strongly associated with anti-calpastatin antibodies in rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1588-93.